Claros Diagnostics has developed a handheld device that will revolutionize disease monitoring by allowing anyone to perform laboratory-quality blood tests in any setting. Based on patented technology from the Harvard laboratory of George Whitesides, this system reduces diagnosis time from days to minutes, eliminates the need for technical expertise, and cuts out 99% of capital costs compared to centralized testing. As an initial product, Claros will provide a quantitative test for use in physician offices, emergency rooms, and fertility clinics for monitoring pregnancy, an USD 800 million market opportunity. Claros will further release tests for other similar-sized segments of the in-vitro diagnostics
(IVD) market. Submit to
info@kti-cti.ch
